
Vol. 80, Suppl. 1, 2004
Free Abstract
Article (Fulltext)
Article (PDF 148 KB)
Current Status of the Diagnosis and Treatment of Hereditary and Sporadic Neuroendocrine Tumors of the Gastroenteropancreatic System European Neuroendocrine Tumor Society (ENETS), Budapest, March 2004 Guest Editor: Bertram Wiedenmann, Berlin
Paper
Gastrinomas: Advances in Diagnosis and Management
Robert T. Jensen
Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md., USA
Address of Corresponding Author
Neuroendocrinology 2004;80 (Suppl. 1):23-27 (DOI: 10.1159/000080736)
Key Words
- Gastrinomas
- Zollinger-Ellison syndrome
- Somatostatin receptor scintigraphy
Abstract
Gastrinomas causing Zollinger-Ellison syndrome (ZES) are the most common functional, malignant pancreatic endocrine tumors. In this paper, the diagnosis and treatment of these tumors are reviewed, incorporating recent advances in each area. Furthermore, recent advances in their pathology, molecular pathogenesis, and aspects of their localization using somatostatin receptor scintigraphy, as well as their treatment are discussed. Recent data from our NIH prospective studies on patients with ZES are included to illustrate many of these points. Copyright © 2004 S. Karger AG, Basel
Author Contacts
Robert T. Jensen NIH/NIDDK/DDB, Bldg. 10, Rm. 9C-103 10 Center DR MSC 1804 Bethesda MD 20892-1804 (USA) Tel. +1 301 496 4201, Fax +1 301 402 0600, E-Mail robertj@bdg10.niddk.nih.gov
Article Information
Number of Print Pages : 5
Number of Figures : 2, Number of Tables : 2, Number of References : 18 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|